These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 8061394)

  • 1. Possible gliclazide-induced water retention with azotemia.
    Kamikubo K; Takami R; Suwa T; Sugiyama A; Horibe N; Sakata S
    Intern Med; 1994 Mar; 33(3):163-4. PubMed ID: 8061394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of blood urea nitrogen and serum creatinine concentrations as indicators of renal dysfunction: a study of 111 cases and a review of related literature.
    Finco DR; Duncan JR
    J Am Vet Med Assoc; 1976 Apr; 168(7):593-601. PubMed ID: 1270342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prerenal azotemia: differentiation of hyperureagenesis from renal hypoperfusion using urinary urea nitrogen data.
    Sklar AH; Riesenberg LA; Ur Rehman A; Smith S; Rivera-Padilla H
    Int J Artif Organs; 1996 Mar; 19(3):164-9. PubMed ID: 8675360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gliclazide-induced acute hepatitis.
    Dourakis SP; Tzemanakis E; Sinani C; Kafiri G; Hadziyannis SJ
    Eur J Gastroenterol Hepatol; 2000 Jan; 12(1):119-21. PubMed ID: 10656221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe hyperuricemia in patients with volume depletion.
    Feinstein EI; Quion-Verde H; Kaptein EM; Massry SG
    Am J Nephrol; 1984; 4(2):77-80. PubMed ID: 6720757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing kidney outcomes in type 2 diabetes treated with different sulphonylureas in real-life clinical practice.
    Lee YH; Lee CJ; Lee HS; Choe EY; Lee BW; Ahn CW; Cha BS; Lee HC; Balkau B; Kang ES
    Diabetes Metab; 2015 Jun; 41(3):208-15. PubMed ID: 25687901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benign azotemia of long-term hemodialysis: increase in blood urea nitrogen and serum creatinine concentrations after the initiation of dialysis.
    Abuelo JG
    Am J Med; 1989 Jun; 86(6 Pt 1):738-9. PubMed ID: 2729336
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute generalized exanthematous pustulosis induced by gliclazide: a case report.
    Contreras-Steyls M; Vílchez-Márquez F; Mota A; Moyano B; Herrera-Ceballos E
    Int J Dermatol; 2013 Dec; 52(12):1591-3. PubMed ID: 24261739
    [No Abstract]   [Full Text] [Related]  

  • 9. Gliclazide-Induced Insulin Autoimmune Syndrome: A Rare Case Report and Review on Literature.
    Feng X; Yuan L; Hu Y; Zhu Y; Yang F; Jiang L; Yan R; Luo Y; Zhao E; Liu C; Wang Y; Li Q; Cao X; Li Q; Ma J
    Endocr Metab Immune Disord Drug Targets; 2016; 16(4):230-234. PubMed ID: 28017142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonsteroidal anti-inflammatory drug-associated azotemia in the very old.
    Gurwitz JH; Avorn J; Ross-Degnan D; Lipsitz LA
    JAMA; 1990 Jul; 264(4):471-5. PubMed ID: 2366280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Massive and disproportionate elevation of blood urea nitrogen in acute azotemia.
    Feinfeld DA; Bargouthi H; Niaz Q; Carvounis CP
    Int Urol Nephrol; 2002; 34(1):143-5. PubMed ID: 12549657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azotemia.
    Berman LB
    Ohio State Med J; 1973 Nov; 69(11):844. PubMed ID: 4756384
    [No Abstract]   [Full Text] [Related]  

  • 13. Urinary PC-1 and N-acetyl-beta-D-glucosaminidase activity in patients with type 2 diabetes treated with metformin, gliclazide or glibenclamide.
    Stefanović V; Antić S; Mitić-Zlatković M; Stojiljković S; Milojković M; Bogicević M; Vlahović P
    Ann Clin Biochem; 2003 May; 40(Pt 3):232-4. PubMed ID: 12803833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of gliclazide in the treatment of non-insulin-dependent diabetes mellitus: a Canadian multicenter study.
    Mailhot J
    Clin Ther; 1993; 15(6):1060-8. PubMed ID: 8111803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The efficacy and safety of 30 mg slow-released-gliclazide in type 2 diabetes mellitus].
    Li GW; Pan CY; Gao Y; Yuan SY; Yang WY; Xing XY; Tian H; Guo XH; Li HB
    Zhonghua Nei Ke Za Zhi; 2004 Jul; 43(7):510-4. PubMed ID: 15312405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-renal azotemia mimicking chronic renal failure in a hypotensive patient.
    Darm JR; Bhagavan NV; Scottolini AG
    Clin Chem; 1979 Nov; 25(11):1978-80. PubMed ID: 498510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acute pancreatitis induced by gliclazide].
    Roblin X; Abinader Y; Baziz A
    Gastroenterol Clin Biol; 1992; 16(1):96. PubMed ID: 1537488
    [No Abstract]   [Full Text] [Related]  

  • 18. Is gliclazide a new antidiabetic drug implicated in the pathogenesis of ocular mucous membrane pemphigoid?
    Cozzani E; Di Zenzo G; Cioni M; Javor S; Altieri M; Anselmi L; Parodi A
    Eur J Dermatol; 2018 Jun; 28(3):396-397. PubMed ID: 29547128
    [No Abstract]   [Full Text] [Related]  

  • 19. Familial azotemia. Impaired urea excretion despite normal renal function.
    Hsu CH; Kurtz TW; Massari PU; Ponze SA; Chang BS
    N Engl J Med; 1978 Jan; 298(3):117-21. PubMed ID: 619239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poisoning induced by administration of a phosphate-containing urinary acidifier in a cat.
    Fulton RB; Fruechte LK
    J Am Vet Med Assoc; 1991 Mar; 198(5):883-5. PubMed ID: 2026546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.